GLP-1 based therapies: differential effects on fasting and postprandial glucose.


Glucagon-like peptide-1 (GLP-1), a gut-derived hormone secreted in response to nutrients, has several glucose and weight regulating actions including enhancement of glucose-stimulated insulin secretion, suppression of glucagon secretion, slowing of gastric emptying and reduction in food intake. Because of these multiple effects, the GLP-1 receptor system… (More)
DOI: 10.1111/j.1463-1326.2012.01560.x


5 Figures and Tables